Marion Maetens

Subclonal diversification of primary breast cancer revealed by multiregion sequencing

Lucy Yates, Moritz Gerstung, Stian Knappskog et al. · Nature Medicine · 2015 · 815 citations · Full text

Breast Oncology, Oncology, Tumor Heterogeneity +8

Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells <i>in vivo</i>

Sarah Francoz, Pascal Froment, Sven Bogaerts et al. · Proceedings of the National Academy of Sciences · 2006 · 253 citations · Full text

Tumor Biology, Systems Biology, P53 Stability +12

Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer

Françoise Rothé, J.-F. Laes, Diether Lambrechts et al. · Annals of Oncology · 2014 · 234 citations · Full text

Breast Oncology, Oncology, Cancer Pathology +13

RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy

Debora Fumagalli, David Venet, Michail Ignatiadis et al. · JAMA Oncology · 2016 · 154 citations · Full text

Circulating Tumor DNA in HER2-Amplified Breast Cancer: A Translational Research Substudy of the NeoALTTO Phase III Trial

Françoise Rothé, Maria João Silva, David Venet et al. · Clinical Cancer Research · 2019 · 121 citations · Full text